SrasV1, Main, Exploration, bibRecord, 000C08

US government lifts ban on risky pathogen research.

Identifieur interne : 000C08 ( Main/Exploration ); précédent : 000C07; suivant : 000C09

US government lifts ban on risky pathogen research.

Auteurs : Sara Reardon

Source :

Nature [ 1476-4687 ] ; 2018.

RBID : pubmed:29300039

Descripteurs français

KwdFr :
- Confinement de risques biologiques (), Contrôle de la recherche scientifique, Coronavirus du syndrome respiratoire du Moyen-Orient (génétique), Coronavirus du syndrome respiratoire du Moyen-Orient (pathogénicité), Financement organisé (législation et jurisprudence), Humains, Incertitude, National Institutes of Health (USA) (législation et jurisprudence), National Institutes of Health (USA) (économie), Orthomyxoviridae (génétique), Orthomyxoviridae (pathogénicité), Pandémies (), Recherche à double usage (législation et jurisprudence), Soutien financier à la recherche comme sujet (législation et jurisprudence), Vaccins antiviraux, Virus (génétique), Virus (immunologie), Virus (pathogénicité), Virus du SRAS (génétique), Virus du SRAS (pathogénicité), Épidémiosurveillance, États-Unis d'Amérique, Évaluation des risques ().
MESH :
- génétique : Coronavirus du syndrome respiratoire du Moyen-Orient, Orthomyxoviridae, Virus, Virus du SRAS.
- immunologie : Virus.
- législation et jurisprudence : Financement organisé, National Institutes of Health (USA), Recherche à double usage, Soutien financier à la recherche comme sujet.
- pathogénicité : Coronavirus du syndrome respiratoire du Moyen-Orient, Orthomyxoviridae, Virus, Virus du SRAS.
- économie : National Institutes of Health (USA).
- Confinement de risques biologiques, Contrôle de la recherche scientifique, Humains, Incertitude, Pandémies, Vaccins antiviraux, Épidémiosurveillance, États-Unis d'Amérique, Évaluation des risques.

English descriptors

KwdEn :
- Censorship, Research, Containment of Biohazards (methods), Dual Use Research (legislation & jurisprudence), Epidemiological Monitoring, Financing, Organized (legislation & jurisprudence), Gain of Function Mutation, Humans, Middle East Respiratory Syndrome Coronavirus (genetics), Middle East Respiratory Syndrome Coronavirus (pathogenicity), National Institutes of Health (U.S.) (economics), National Institutes of Health (U.S.) (legislation & jurisprudence), Orthomyxoviridae (genetics), Orthomyxoviridae (pathogenicity), Pandemics (prevention & control), Research Support as Topic (legislation & jurisprudence), Risk Assessment (methods), SARS Virus (genetics), SARS Virus (pathogenicity), Uncertainty, United States, Viral Vaccines, Viruses (genetics), Viruses (immunology), Viruses (pathogenicity).
MESH :
- chemical : Viral Vaccines.
- economics : National Institutes of Health (U.S.).
- genetics : Middle East Respiratory Syndrome Coronavirus, Orthomyxoviridae, SARS Virus, Viruses.
- immunology : Viruses.
- legislation & jurisprudence : Dual Use Research, Financing, Organized, National Institutes of Health (U.S.), Research Support as Topic.
- methods : Containment of Biohazards, Risk Assessment.
- pathogenicity : Middle East Respiratory Syndrome Coronavirus, Orthomyxoviridae, SARS Virus, Viruses.
- prevention & control : Pandemics.
- Censorship, Research, Epidemiological Monitoring, Gain of Function Mutation, Humans, Uncertainty, United States.

DOI: 10.1038/d41586-017-08837-7
PubMed: 29300039

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">US government lifts ban on risky pathogen research.</title>
<author><name sortKey="Reardon, Sara" sort="Reardon, Sara" uniqKey="Reardon S" first="Sara" last="Reardon">Sara Reardon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29300039</idno>
<idno type="pmid">29300039</idno>
<idno type="doi">10.1038/d41586-017-08837-7</idno>
<idno type="wicri:Area/PubMed/Corpus">000A34</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A34</idno>
<idno type="wicri:Area/PubMed/Curation">000A34</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A34</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000943</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000943</idno>
<idno type="wicri:Area/Ncbi/Merge">002E96</idno>
<idno type="wicri:Area/Ncbi/Curation">002E96</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002E96</idno>
<idno type="wicri:Area/Main/Merge">000C10</idno>
<idno type="wicri:Area/Main/Curation">000C08</idno>
<idno type="wicri:Area/Main/Exploration">000C08</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">US government lifts ban on risky pathogen research.</title>
<author><name sortKey="Reardon, Sara" sort="Reardon, Sara" uniqKey="Reardon S" first="Sara" last="Reardon">Sara Reardon</name>
</author>
</analytic>
<series><title level="j">Nature</title>
<idno type="eISSN">1476-4687</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Censorship, Research</term>
<term>Containment of Biohazards (methods)</term>
<term>Dual Use Research (legislation & jurisprudence)</term>
<term>Epidemiological Monitoring</term>
<term>Financing, Organized (legislation & jurisprudence)</term>
<term>Gain of Function Mutation</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus (genetics)</term>
<term>Middle East Respiratory Syndrome Coronavirus (pathogenicity)</term>
<term>National Institutes of Health (U.S.) (economics)</term>
<term>National Institutes of Health (U.S.) (legislation & jurisprudence)</term>
<term>Orthomyxoviridae (genetics)</term>
<term>Orthomyxoviridae (pathogenicity)</term>
<term>Pandemics (prevention & control)</term>
<term>Research Support as Topic (legislation & jurisprudence)</term>
<term>Risk Assessment (methods)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (pathogenicity)</term>
<term>Uncertainty</term>
<term>United States</term>
<term>Viral Vaccines</term>
<term>Viruses (genetics)</term>
<term>Viruses (immunology)</term>
<term>Viruses (pathogenicity)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Confinement de risques biologiques ()</term>
<term>Contrôle de la recherche scientifique</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (génétique)</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient (pathogénicité)</term>
<term>Financement organisé (législation et jurisprudence)</term>
<term>Humains</term>
<term>Incertitude</term>
<term>National Institutes of Health (USA) (législation et jurisprudence)</term>
<term>National Institutes of Health (USA) (économie)</term>
<term>Orthomyxoviridae (génétique)</term>
<term>Orthomyxoviridae (pathogénicité)</term>
<term>Pandémies ()</term>
<term>Recherche à double usage (législation et jurisprudence)</term>
<term>Soutien financier à la recherche comme sujet (législation et jurisprudence)</term>
<term>Vaccins antiviraux</term>
<term>Virus (génétique)</term>
<term>Virus (immunologie)</term>
<term>Virus (pathogénicité)</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (pathogénicité)</term>
<term>Épidémiosurveillance</term>
<term>États-Unis d'Amérique</term>
<term>Évaluation des risques ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>National Institutes of Health (U.S.)</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Middle East Respiratory Syndrome Coronavirus</term>
<term>Orthomyxoviridae</term>
<term>SARS Virus</term>
<term>Viruses</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Orthomyxoviridae</term>
<term>Virus</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Viruses</term>
</keywords>
<keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Dual Use Research</term>
<term>Financing, Organized</term>
<term>National Institutes of Health (U.S.)</term>
<term>Research Support as Topic</term>
</keywords>
<keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Financement organisé</term>
<term>National Institutes of Health (USA)</term>
<term>Recherche à double usage</term>
<term>Soutien financier à la recherche comme sujet</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Containment of Biohazards</term>
<term>Risk Assessment</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Middle East Respiratory Syndrome Coronavirus</term>
<term>Orthomyxoviridae</term>
<term>SARS Virus</term>
<term>Viruses</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Orthomyxoviridae</term>
<term>Virus</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>National Institutes of Health (USA)</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Censorship, Research</term>
<term>Epidemiological Monitoring</term>
<term>Gain of Function Mutation</term>
<term>Humans</term>
<term>Uncertainty</term>
<term>United States</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Confinement de risques biologiques</term>
<term>Contrôle de la recherche scientifique</term>
<term>Humains</term>
<term>Incertitude</term>
<term>Pandémies</term>
<term>Vaccins antiviraux</term>
<term>Épidémiosurveillance</term>
<term>États-Unis d'Amérique</term>
<term>Évaluation des risques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Reardon, Sara" sort="Reardon, Sara" uniqKey="Reardon S" first="Sara" last="Reardon">Sara Reardon</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C08 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C08 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29300039
   |texte=   US government lifts ban on risky pathogen research.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29300039" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

Serveur d'exploration SRAS

US government lifts ban on risky pathogen research.

US government lifts ban on risky pathogen research.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.